Journal of Pediatric Neurology 2011; 09(03): 299-304
DOI: 10.3233/JPN-2011-0501
Georg Thieme Verlag KG Stuttgart – New York

Interleukin-1β, interleukin-6, and tumor necrosis factor-α in the cerebrospinal fluid of term infants with hypoxic-ischemic encephalopathy after postnatal treatment with magnesium sulfate

Mohamed T. Khashaba
a   Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt
,
Basma O. Shouman
a   Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt
,
Bothina M. Hasanein
a   Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt
,
Ali A. Shaltout
a   Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt
,
Hala M. Al-Marsafawy
a   Department of Pediatrics, Mansoura University Children's Hospital, Mansoura, Egypt
,
Mohamed M. Abdel-Aziz
b   Department of Gastroenterology, Mansoura University, Mansoura, Egypt
,
Tahmina Ahmad
c   Department of Newborn Services, The George Washington University and the Children's National Medical Center, Washington, DC, USA
,
Hany Aly
c   Department of Newborn Services, The George Washington University and the Children's National Medical Center, Washington, DC, USA
› Author Affiliations

Subject Editor:
Further Information

Publication History

23 September 2010

03 January 2011

Publication Date:
30 July 2015 (online)

Abstract

Proinflammatory cytokines play a role in the pathogenesis of hypoxic-ischemic encephalopathy (HIE). We aimed: 1) to characterize the expression of interleukin-1β (IL-1β), IL-6 and tumor necrosis factor-α (TNF-α) in the cerebrospinal fluid (CSF) of term infants with HIE, and 2) to determine the impact of a single dose of magnesium sulfate (MgSO4) on their concentrations. We analyzed the samples of CSF that were collected during a randomized controlled trial on the use of MgSO4 in neonatal asphyxia. Two samples were obtained from each subject; one was obtained on admission and the second sample was collected at 72 hr of life. The grades of HIE in the 47 included newborns were mild (n = 15), moderate (n = 17), and severe (n = 15). After the collection of the first CSF sample, 23 newborns received a single dose of MgSO4, whereas the other 24 newborns received an equal volume of normal saline placebo. Concentrations of IL-1β, IL-6 and TNF-α in the CSF were quantified by enzyme-linked immunosorbent assay in all CSF samples. The initial concentration of IL-1β and IL-6 correlated with the severity grades of HIE (P = 004 and P = 0001, respectively) while TNF-α did not. At 72 hr, a significant decline in the concentration of TNF-α (pg/mL) was observed in samples of MgSO4-treated infants when compared to the control group (–28 ± 90 vs. 102 ± 404, P = 0.01), whereas the two treatment groups did not differ in IL-1β or IL-6. Short-term clinical outcomes correlated best with IL-1β at baseline, IL-6 at baseline and IL-6 at 72 hr. We conclude that cytokine activation, as manifested by increased IL-1β and IL-6 in the CSF, is positively correlated with the severity of HIE. Treatment with a single dose of MgSO4 was efficacious in aborting the activation of TNF-α but did not alter the expression of IL-1β or IL-6.